2026³â 06¿ù 30ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 103659°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



LIG D&A-¶óÀθÞÅ», ÇÕÀÛȸ»ç ¼³¸³ ÃßÁø

À¯·´¡¤NATO ´ÙÃþ ¹æ°ø ü°è ±¸Ãà Çù·Â
LIG µðÆæ½º ¿¡¾î·Î½ºÆäÀ̽º(ÀÌÇÏ LIG D&A)¿Í ¶óÀθÞÅ» ¿¡¾îµðÆæ½º(ÀÌÇÏ ¶óÀθÞÅ»)°¡ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î°í À¯·´ ¹× ³ªÅä(NATO)¿¡ ´ëÇÑ Ã·´Ü ¹æ°ø ½Ã½ºÅÛ °ø±ÞÀ» À§ÇØ Àü¹æÀ§Àû Çù·ÂÀ» ÃßÁøÇÑ´Ù. ¾ç»ç´Â À¯·´ ³» ´ÙÃþ ¹æ°ø ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ´Â »óȲ¿¡¼­ °í°´ ¿ä±¸¿¡ ºÎÇÕÇÏ´Â ÅëÇÕ ¹æ°ø ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Çù·Â ¹æ¾ÈÀ» ³íÀÇÇϰí ÀÖ´Ù. À̸¦ À§ÇÑ Ã¹ Çຸ·Î LIG¿Í ¶óÀθÞÅ» °£ÀÇ À¯·´ ³» ÇÕÀÛȸ»ç ¼³¸³°ú °ü·ÃÇÑ ³íÀǸ¦ ½Éµµ ÀÖ°Ô ÁøÇà ÁßÀÌ´Ù. À̹ø Çù·ÂÀ» ÅëÇØ ¾ç»ç´Â »óÈ£ º¸¿ÏÀûÀÎ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ±â¹ÝÀ¸·Î À¯·´ ...

¡®ÇÏÆ®½Ã±×³Î5¡¯ ÀÔÁÖÀÚ 8ÀÎ, ÀϺ» µµÄí½Ã¸¶·Î ¿©Çà ¶°³ª

¼³·½°ú ÁúÅõÀÇ ¼Ò¿ëµ¹ÀÌ ¿¹°í
‘ÇÏÆ®½Ã±×³Î5’ ÀÔÁÖÀÚ 8ÀÎÀÌ È¥µ·ÀÇ ·¯ºê¶óÀÎ ¼Ó ÀϺ» µµÄí½Ã¸¶·Î ¿©ÇàÀ» ¶°³­´Ù. 19ÀÏ(È­) ¹ã 10½Ã ¹æ¼ÛµÇ´Â ä³ÎA ‘ÇÏÆ®½Ã±×³Î5’(¿¬Ãâ ¹Úöȯ, ±èÈ«±¸) 6ȸ¿¡¼­´Â ‘½Ã±×³Î ÇϿ콺’ ÀÔÁÖÀÚ 8ÀÎ(¹Ú¿ì¿­-±è¼º¹Î-±è¼­¿ø-Á¤ÁØÇö-±è¹ÎÁÖ-Á¤±Ô¸®-°­À¯°æ-ÃÖ¼ÒÀ±)ÀÌ ÀϺ» µµÄí½Ã¸¶¿¡¼­ ¿©ÇàÀ» °âÇÑ µ¥ÀÌÆ®¸¦ ÇÏ¸ç º¹ÀâÇÑ °¨Á¤ÀÇ ¼Ò¿ëµ¹ÀÌ¿¡ ºüÁö´Â ¸ð½ÀÀÌ ´ã±ä´Ù. À̳¯ ÀϺ»¿¡ µµÂøÇÑ ÀÔÁÖÀÚµéÀº Â÷¸¦ Ÿ°í ¹Ù´å°¡·Î À̵¿ÇÑ´Ù. Â÷ ¾È¿¡¼­ °­À¯°æÀº ¹Ú¿ì¿­ÀÇ ¿·ÀÚ¸®¿¡ ¾É¾Æ ¹à°Ô ¿ô°í, Â÷°¡ Èçµé¸®ÀÚ ¹Ú ...

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its Firs...

Marks first launch in Japan through partnership with NIPRO CORPORATION.
INCHEON, KOREA -- Samsung Bioepis Co., Ltd. announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in Japan under partnership with NIPRO CORPORATION (hereafter “NIPRO”). The launch follows the Official Gazette announcement on May 19 regarding the product’s listing under the National Health Insurance (NHI) Drug Price Standard, which became effective tod ...
µðÁî´Ï ij¸¯Å͵é°úÀÇ ¶æ¹ÛÀÇ ¸¸³², ÀÌ»öÀûÀÎ ¸ðÇè (2024-09-01)
Lineage Acquires Warehousing and e-Commerce Assets of Burris... (2023-10-04)
Biocytogen Enters into Antibody Licensing Agreement with BeO... (2025-07-24)
ǰ°í, ¼Ò»ó°øÀÎÀÇ ¼ºÀå Áö¿øÇÏ´Â »ó»ý °æ¿µ (2023-10-22)
¾î¹ÝµðÄÉÀÌ, ·ÎÄà ¾Ú¹ö¼­´õ·Î ¸ðµ¨ '¹ÚÁ¦´Ï' ¹ßŹ (2024-01-07)
âÀÇÀûÀ̰í ȹ±âÀûÀÎ AI ½º¸¶Æ®ÀüÀÚ¹ßÀü±âAISEG (2023-12-13)
¸ñÆ÷ ¹è°æÀ¸·Î ÇÑ À̾߱â¿Í °ø¿¬ ±×¸®°í ÇÑ ³¢ ½Ä»ç (2023-10-06)
Æ®¿ÍÀ̽º ´ÙÇö, ¾îÇ»¿Í ±Û·Î¹ú ¿Â¶óÀÎ ÆÒ¹ÌÆÃ (2024-07-31)
¼ö±¹ÀÇ ¼¶ µµÃʵµ 'È«¾î Àå¼ö ¹®¼øµæ ÃàÁ¦ 2024 ¹®Æä½ºÅ¸' (2024-06-27)
Áß±¹, ÀÚº» À¯ÃâµÇµµ ÇØ¿Ü ¼øÀÚ»ê Áõ°¡ (2016-06-08)
¼îÇÇÄÚ¸®¾Æ, º£Æ®³² KÁ¦Ç° ÁÖ¹® °Ç¼ö 4¹è Áõ°¡ (2024-03-26)
°í¹°°¡ ½Ã´ë ¹Ý°¡¿î ¡®BC ¹Ù·Î MACAO Ä«µå¡¯ Ãâ½Ã (2024-07-15)
¼¼À̺ê¤, ¼¼°è ÃÖ°í ¼öÁØ ÁöÆÛ·Î ±Û·Î¹ú ½ÃÀå ÁøÃâ (2024-06-11)
ģȯ°æ °¡Ä¡ È®»êÇÏ´Â ÆË¾÷½ºÅä¾î ¡®Ç÷£Æ¼¡¯ ½ÃÁð2 ·ÐĪ (2024-08-27)
¿µÈ­ ¡®»þÀΡ¯ ÀåÇØ±Ý, ¡®10´ë ³¡ÀÚ¶ô¡¯ °¨¼º ´ãÀº È­º¸ (2024-08-02)
IQM and TOYO Corporation Sign Distribution Agreement to Driv... (2025-08-29)
SES SCORE Surpasses 600,000 of Transmission Hours, Deliverin... (2025-10-02)
Ŭ·»Â¡ ºê·£µå ¼¾Ä« Ŭ·»Â¡, »õ ¾Ú¹ö¼­´õ ¿µÈÆ È­º¸ °ø°³ (2024-12-09)
Philip Morris International Launches New IQOS ILUMA i in Jap... (2024-03-21)
J©ªrgen Vig Knudstorp Nominated to Join NIKE, Inc. Board of ... (2025-07-01)
KYMF´ëÇѹα¹Ã»¼Ò³â¹Ìµð¾î´ëÀü, ÀÛǰ °ø¸ð (2025-08-04)
Çö´ëÀÚµ¿Â÷, 2024³â Àӱݱ³¼· ¡®6³â ¿¬¼Ó ¹«ºÐ±Ô¡¯ ÀáÁ¤ÇÕÀÇ (2024-07-10)
¡®»þÀΡ¯ ¿©ÁÖÀΰø ÀåÇØ±Ý, ¿µÈ­°è ÁÖ¸ñÇÒ ¹è¿ì ÀÎÅͺä È­º¸ (2024-08-13)
¾¾¿£Æ¼Å×Å©, Ãʱââ¾÷ÆÐŰÁö 101¸àÅ丵 Âü¿©±â¾÷ ¸ðÁý (2024-08-13)
Korean Unicorn APR Files for Preliminary IPO Review on KRX (2023-09-26)
       [ÀÌÀü][1]....[1004][1005][1006][1007][1008][1009][1010][1011][1012]...[4147][´ÙÀ½]

°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..